StockData
Innospec Inc. logo

Innospec Inc. (IOSP) stock

IOSPNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3015% below fair value
$78.86+0.85 (+1.09%)

Close on Nov 18, 2026Market cap $1.94BP/E –Yield 2.17%

Innospec revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Innospec's revenue for the twelve months ending Jun 30, 2026 was $1.84B, up 2.9% year over year. For fiscal 2025 it was $1.78B, down 3.7% from the year before. Over ten years it grew 5.8% a year on average. The highest annual figure on record is $1.96B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.78B-3.7%
FY2024Dec 31, 2024$1.85B-5.3%
FY2023Dec 31, 2023$1.95B-0.8%
FY2022Dec 31, 2022$1.96B+32.4%
FY2021Dec 31, 2021$1.48B+24.3%
FY2020Dec 31, 2020$1.19B-21.2%
FY2019Dec 31, 2019$1.51B+2.5%
FY2018Dec 31, 2018$1.48B+13.0%
FY2017Dec 31, 2017$1.31B+47.9%
FY2016Dec 31, 2016$883.40M-12.7%
FY2015Dec 31, 2015$1.01B+5.3%
FY2014Dec 31, 2014$960.90M+17.4%
FY2013Dec 31, 2013$818.80M+5.5%
FY2012Dec 31, 2012$776.40M+0.3%
FY2011Dec 31, 2011$774.40M+13.3%
FY2010Dec 31, 2010$683.20M+14.2%
FY2009Dec 31, 2009$598.50M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$491.40M+11.8%
Q1 FY2026Mar 31, 2026$453.20M+2.8%
Q4 FY2025Dec 31, 2025$455.60M-2.4%
Q3 FY2025Sep 30, 2025$441.90M-0.3%
Q2 FY2025Jun 30, 2025$439.70M+1.1%
Q1 FY2025Mar 31, 2025$440.80M-11.9%
Q4 FY2024Dec 31, 2024$466.80M-5.6%
Q3 FY2024Sep 30, 2024$443.40M-4.5%
Q2 FY2024Jun 30, 2024$435.00M-9.5%
Q1 FY2024Mar 31, 2024$500.20M-1.8%
Q4 FY2023Dec 31, 2023$494.70M-3.1%
Q3 FY2023Sep 30, 2023$464.10M-9.5%
Q2 FY2023Jun 30, 2023$480.40M+2.7%
Q1 FY2023Mar 31, 2023$509.60M+7.9%
Q4 FY2022Dec 31, 2022$510.70M+23.6%
Q3 FY2022Sep 30, 2022$513.00M+36.4%
Q2 FY2022Jun 30, 2022$467.60M+31.9%
Q1 FY2022Mar 31, 2022$472.40M+39.1%
Q4 FY2021Dec 31, 2021$413.20M+32.9%
Q3 FY2021Sep 30, 2021$376.10M+41.9%
Q2 FY2021Jun 30, 2021$354.50M+44.8%
Q1 FY2021Mar 31, 2021$339.60M-8.8%
Q4 FY2020Dec 31, 2020$310.80M-20.5%
Q3 FY2020Sep 30, 2020$265.10M-28.7%
Q2 FY2020Jun 30, 2020$244.90M-32.4%
Q1 FY2020Mar 31, 2020$372.30M-4.1%
Q4 FY2019Dec 31, 2019$390.70M-1.1%
Q3 FY2019Sep 30, 2019$371.90M+2.4%
Q2 FY2019Jun 30, 2019$362.40M+1.2%
Q1 FY2019Mar 31, 2019$388.30M+7.7%
Q4 FY2018Dec 31, 2018$395.00M+11.6%
Q3 FY2018Sep 30, 2018$363.10M+9.2%
Q2 FY2018Jun 30, 2018$358.10M+9.7%
Q1 FY2018Mar 31, 2018$360.70M+22.6%
Q4 FY2017Dec 31, 2017$353.80M+48.8%
Q3 FY2017Sep 30, 2017$332.40M+61.8%
Q2 FY2017Jun 30, 2017$326.30M–
Q1 FY2017Mar 31, 2017$294.30M–
Q4 FY2016Dec 31, 2016$237.80M–
Q3 FY2016Sep 30, 2016$205.50M–

More Innospec figures

See a number that looks wrong?